Literature DB >> 7972111

Detection and classification of mutagens: a set of base-specific Salmonella tester strains.

P Gee1, D M Maron, B N Ames.   

Abstract

A detection and classification system for mutagens has been developed that identifies the six possible base-pair substitution mutations. A set of six Salmonella typhimurium (TA7001 to TA7006) strains has been constructed, each of which carries a unique missense mutation in the histidine biosynthetic operon. In addition to the his mutation, these strains carry different auxiliary features that enhance the mutability of the target his mutation. These include the R factor pKM101, which has the SOS-inducible mucAB system; a deletion of the uvrB component of excision repair; and rfa mutations to increase the accessibility of bulky chemicals to the bacteria. Another set of strains (TA7041 to TA7046) contain a wild-type rfa gene. Reversion via the base substitution unique to each strain was verified by sequence analyses of > 800 revertants obtained from different types of mutagens. The strains have considerably lower spontaneous reversion frequencies and detect a variety of mutagens at a sensitivity comparable to the Salmonella tester strains TA100, TA102, and TA104. The low spontaneous frequency of reversion of a mixture of the six tester strains (approximately 10 revertants per plate) enables a single mutation assay with the mixture that is followed by classification of the type of mutation with the individual strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972111      PMCID: PMC45280          DOI: 10.1073/pnas.91.24.11606

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I.

Authors:  S M Hecht; D E Berry; L J MacKenzie; R W Busby; C A Nasuti
Journal:  J Nat Prod       Date:  1992-04       Impact factor: 4.050

2.  Galactose mutants of Salmonella typhimurium.

Authors:  T FUKASAWA; H NIKAIDO
Journal:  Genetics       Date:  1961-10       Impact factor: 4.562

Review 3.  Plasmid transformation of Escherichia coli and other bacteria.

Authors:  D Hanahan; J Jessee; F R Bloom
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping.

Authors:  R G Wilkinson; P Gemski; B A Stocker
Journal:  J Gen Microbiol       Date:  1972-05

5.  The tautomeric state of N(4)-hydroxy- and of N(4)-amino-cytosine derivatives.

Authors:  D M Brown; M J Hewlins; P Schell
Journal:  J Chem Soc Perkin 1       Date:  1968

Review 6.  p53: at the crossroads of molecular carcinogenesis and risk assessment.

Authors:  C C Harris
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

7.  Tandem duplications of the histidine operon observed following generalized transduction in Salmonella typhimurium.

Authors:  R P Anderson; C G Miller; J R Roth
Journal:  J Mol Biol       Date:  1976-08-05       Impact factor: 5.469

Review 8.  Classification and mapping of spontaneous and induced mutations in the histidine operon of Salmonella.

Authors:  P E Hartman; Z Hartman; R C Stahl
Journal:  Adv Genet       Date:  1971       Impact factor: 1.944

9.  A phage P22 gene controlling integration of prophage.

Authors:  H O Smith; M Levine
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

10.  ICR-induced frameshift mutations in the histidine operon of Salmonella.

Authors:  N S Oeschger; P E Hartman
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

View more
  12 in total

1.  A toxic mutator and selection alternative to the non-Mendelian RNA cache hypothesis for hothead reversion.

Authors:  Luca Comai; Reed A Cartwright
Journal:  Plant Cell       Date:  2005-11       Impact factor: 11.277

2.  Selective water-soluble gelatinase inhibitor prodrugs.

Authors:  Major Gooyit; Mijoon Lee; Valerie A Schroeder; Masahiro Ikejiri; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2011-09-06       Impact factor: 7.446

Review 3.  Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

4.  Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

Authors:  Zhipei Liu; Manfred Hergenhahn; Heinz H Schmeiser; Gerald N Wogan; Amanda Hong; Monica Hollstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

5.  Saccharomyces cerevisiae JEN1 promoter activity is inversely related to concentration of repressing sugar.

Authors:  Prima Chambers; Aminatu Issaka; Sean P Palecek
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

6.  Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Rachel Ashworth; Shane R Wilkinson; Marcel Kaiser; Grasiella Andriani; Ana Rodriguez
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

7.  Biosynthesis of Histidine.

Authors:  Malcolm E Winkler; Smirla Ramos-Montañez
Journal:  EcoSal Plus       Date:  2009-08

Review 8.  Mutational spectra of human cancer.

Authors:  Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Hum Genet       Date:  2009-03-24       Impact factor: 4.132

Review 9.  The Salmonella mutagenicity assay: the stethoscope of genetic toxicology for the 21st century.

Authors:  Larry D Claxton; Gisela de A Umbuzeiro; David M DeMarini
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

10.  The strains recommended for use in the bacterial reverse mutation test (OECD guideline 471) can be certified as non-genetically modified organisms.

Authors:  Kei-Ichi Sugiyama; Masami Yamada; Takumi Awogi; Atsushi Hakura
Journal:  Genes Environ       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.